Protagonist Therapeutics, Inc

Pharmaceutical Preparations·NEWARK, CA·FY end 12/31·CIK 1377121

CEO Pay Ratio

30:1

Dinesh V. Patel

CEO Total Comp

$12.9M

Dinesh V. Patel

Median Employee

$428,422

Revenue

—

FY 2025

Net Income

-$130.1M

FY 2025

Free Cash Flow

$56.1M

FY 2025

Net Margin

—

Insider Net (180d)

-$59.8M

0 buys / 42 sales

CEO Pay Accountability

CEO comp as % of net income

-9.89%

For every $1,000 of profit, $-98.90 flows to the CEO.

CEO comp as % of buybacks

—

No buyback data for the most recent fiscal year.

5-year history · USD

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	Trend
Revenue	—	—	—	—	—	—
Gross Profit	—	—	—	—	—	—
Operating Income	-$158.1M	$252.8M	-$93.7M	-$131.4M	-$125.8M
Net Income	-$130.1M	$275.2M	-$79.0M	-$127.4M	-$125.6M
Operating CF	$57.7M	$184.2M	-$70.2M	-$108.1M	-$107.9M
Capex	$1.6M	$1.4M	$609.0K	$795.0K	$1.1M
Free Cash Flow	$56.1M	$182.8M	-$70.8M	-$108.9M	-$109.0M
Buybacks	—	—	—	—	—	—
Dividends	—	—	—	—	—	—

Gross Margin	—	—	—	—	—	—
Operating Margin	—	—	—	—	—	—
Net Margin	—	—	—	—	—	—
FCF Margin	—	—	—	—	—	—
R&D / Revenue	—	—	—	—	—	—
Effective Tax	-0.6%	1.5%	0.0%	0.0%	0.0%
Debt / Equity	—	—	—	—	—	—
Buybacks / FCF	—	—	—	—	—	—

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
Dinesh V. PatelPh.D. President and Chief Executive Officer	$715.5K	$5.8M	$5.6M	$686.9K	$11.9K	$12.9M
Arturo MolinaM.D., M.S., F.A.C.P. Chief Medical Officer	$572.0K	$1.6M	$1.5M	$366.1K	$11.9K	$4.1M
Asif AliEVP, Chief Financial Officer	$500.0K	$1.2M	$1.2M	$320.0K	$6.2K	$3.3M